Nasodine Nasal Spray phase 3 clinical trial : Firebrick Pharma completes 82% patient recruitment
Firebrick Pharma, an ASX-listed pharmaceutical company, announced that it has successfully enrolled 160 subjects in the confirmatory phase 3 clinical trial of Nasodine Nasal Spray ... Read More
Norovirus symptoms, transmission, prevention, treatment
Norovirus is a contagious disease which is the most prevalent cause of acute gastroenteritis in the globe, producing an estimated 685 million cases yearly according ... Read More
Pfizer gets FDA approval for tick-borne encephalitis vaccine TICOVAC
Pfizer has secured approval for its TICOVAC vaccine from the US Food and Drug Administration (FDA) for active immunization against tick-borne encephalitis (TBE) in individuals ... Read More
India clears Zydus Cadila’s Virafin for treatment of moderate Covid-19
Zydus Cadila has secured restricted emergency use approval for ‘Virafin’, Pegylated Interferon alpha-2b (PegIFN) from the Drug Controller General of India (DCGI) for the treatment ... Read More
DNA-based COVID-19 vaccine candidate being developed by University of Waterloo
DNA-based COVID-19 vaccine candidate : Researchers at the University of Waterloo in Canada are developing a DNA-based vaccine candidate which can be given via nasal ... Read More
Traveler brings Novel Coronavirus in US from Chinese city Wuhan
Wuhan Coronavirus cases in US : The deadly Novel Coronavirus (2019-nCoV infection) has made its way to the US owing to the return of a ... Read More
How to Treat Influenza and Common Cold
Common Cold, a viral infection affects most people especially in winter season. Learn about the common cold symptoms and common cold treatment here. Common Cold is ... Read More